I received my M.D. degree from Harvard Medical School in 1993 and then did a residency in general surgery at Massachusetts General Hospital from 1993-2000. I then went to New York where I completed a 2-year fellowship (from 2000-2002) in pediatric surgery at Columbia-Presbyterian Medical Center. In 2002 I returned to Mass. General to join the Department of Pediatric Surgery. My practice is limited to the surgical care of infants and children, including adolescents. I practice the full spectrum of pediatric surgery. My specific interests are in minimally invasive pediatric surgery and in intestinal disorders. I have an active clinical and basic science research program studying the causes and potential treatments of neurointestinal diseases, including Hirschsprung's disease. My practice is primarily based at Mass. General, but I also see patients every Friday in the North Shore at Salem or Danvers.
I have an active basic science and clinical research program that focuses on improving the diagnosis and treatment of children with disorders of intestinal motility. One example of such a condition is Hirschsprung's disease, a congenital condition in which the lower part of the colon lacks nerve cells. Hirschsprung's disease is associated with severe functional obstruction of the intestine and requires surgery to remove part of the colon. My research is aimed at improving our ability to diagnose and treat children with Hirschsprung's disease. For a complete summary of my research, please go to my lab website - http://www.massgeneral.org/children/research/researchers/Goldsteinlab/default.aspx.
Pediatric surgeon Allan Goldstein, MD, has kept his promise to a young patient with Hirschsprung’s disease.
Allan Goldstein, MD, FACS, director of the Pediatric Neurogastroenterology Program, has been appointed chief of the Division of Pediatric Surgery for MassGeneral Hospital for Children (MGHfC) and will lead the division’s clinical, education, research and community service activities.
Dr. Allan Goldstein researches the development of the enteric nervous system, including the causes of distal aganglionosis, causes and possible treatments of Hirschsprung-associated enterocolitis (HAEC), and neuronal cell transplantation, a novel treatment approach for Hirschsprung disease.
The REACH Symposium (Research, Education, and Awareness for Children with Hirschsprung's disease) is a multidisciplinary conference highlighting important and up-to-date clinical and scientific topics in Hirschsprung's disease.